Literature DB >> 17822515

Pathogenesis of haemophilic synovitis: experimental studies on blood-induced joint damage.

L A Valentino1, N Hakobyan, N Rodriguez, W K Hoots.   

Abstract

Hemarthrosis is a common manifestation of haemophilia, and joint arthropathy remains a frequent complication. Even though the exact mechanisms related to blood-induced joint disease have not yet been fully elucidated, it is likely that iron deposition in the synovium induces an inflammatory response that causes not only immune system activation but also stimulates angiogenesis. This process ultimately results in cartilage and bone destruction. Investigating the processes that occur in the early stages of blood-induced joint disease in humans has been very limited. Therefore, the use of haemophilic animal models is critical to augment the understanding of this phenomenon. This article discusses three cellular regulators (p53, p21 and TRAIL) induced in synovial tissue that are important for iron metabolism. A cartilage remodelling programme induced by the release of cytokines and growth factors that result in articular damage is also discussed. Full elucidation of the pathogenesis of haemophilic joint disease is required to identify new avenues for prevention and therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17822515     DOI: 10.1111/j.1365-2516.2007.01534.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  13 in total

1.  The effect of secondary prophylaxis versus episodic treatment on the range of motion of target joints in patients with haemophilia.

Authors:  Sweta Gupta; Azfar-E-Alam Siddiqi; J Michael Soucie; Marilyn Manco-Johnson; Roshni Kulkarni; Heidi Lane; Robina Ingram-Rich; Joan C Gill
Journal:  Br J Haematol       Date:  2013-02-22       Impact factor: 6.998

2.  Joint scores in hemophilic arthropathy in children: Developing country perspectives.

Authors:  Aritra Guha; Akash Rai; Arnab Nandy; Tanushree Mondal; Narayan Pandit; Sumantra Guha; Dipankar Gupta; Rakesh Mondal
Journal:  Eur J Rheumatol       Date:  2019-12-16

3.  A preliminary case series evaluating the safety and immediate to short-term clinical benefits of joint mobilization in hemophilic arthritis of the lower limb.

Authors:  Emma Scaddan; John Rowell; Shaun O'Leary
Journal:  J Man Manip Ther       Date:  2016-11-17

4.  Radiosynoviorthesis in hemophilic arthropathy: pathologic blood pool imaging on pre-therapeutic bone scintigraphy is not a predictor of treatment success.

Authors:  Amir Sabet; Andreas Christian Strauss; Jan Schmolders; Rahel Bornemann; Amin Sabet; Johannes Oldenburg; Peter Hans Pennekamp; Hans Juergen Biersack; Samer Ezziddin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-10-28       Impact factor: 9.236

5.  The effect of chemically defined medium on spontaneous calcium signaling of in situ chondrocytes during long-term culture.

Authors:  Yilu Zhou; Miri Park; Enoch Cheung; Liyun Wang; X Lucas Lu
Journal:  J Biomech       Date:  2015-02-07       Impact factor: 2.712

6.  Musculoskeletal complications of hemophilia.

Authors:  E Carlos Rodriguez-Merchan
Journal:  HSS J       Date:  2009-11-17

7.  Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival.

Authors:  Marc Baud'huin; Laurence Duplomb; Stéphane Téletchéa; Céline Charrier; Mike Maillasson; Marc Fouassier; Dominique Heymann
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

Review 8.  Orthopedic disorders of the knee in hemophilia: A current concept review.

Authors:  E Carlos Rodriguez-Merchan; Leonard A Valentino
Journal:  World J Orthop       Date:  2016-06-18

Review 9.  Clinical and laboratory approaches to hemophilia a.

Authors:  Hassan Mansouritorghabeh
Journal:  Iran J Med Sci       Date:  2015-05

Review 10.  Ultrasound for Early Detection of Joint Disease in Patients with Hemophilic Arthropathy.

Authors:  Matteo Nicola Dario Di Minno; Gianluigi Pasta; Sonia Airaldi; Federico Zaottini; Antonio Storino; Ernesto Cimino; Carlo Martinoli
Journal:  J Clin Med       Date:  2017-07-31       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.